Dopamine and norepinephrine activity in schizophrenia. An integrative perspective

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• The dopamine (DA) hypothesis of schizophrenia initially proposed increased DA activity as the primary cause.
• Recent findings indicate decreased DA activity in chronic and remitted schizophrenia, potentially linked to deficit symptoms and cortical lesions.

Purpose of the Study:

• To review and synthesize current findings on the roles of dopamine and norepinephrine (NE) in schizophrenia.
• To support the hypothesis that dysregulation in both DA and NE systems contributes to schizophrenic behavior.

Main Methods:

• Review of existing scientific literature and data on DA and NE systems in schizophrenia patients.
• Analysis of findings in relation to basic science principles and current hypotheses.
• Emphasis on the interaction between neural development, genetic predisposition, and environmental factors.

Main Results:

• Increased DA activity is associated with psychotic symptoms and response to antipsychotic drugs.
• Decreased DA activity is observed in chronic and remitted states, correlating with deficit symptoms.
• The norepinephrine (NE) system is implicated in schizophrenia symptomatology, treatment response, and disease course.

Conclusions:

• A disturbance in both dopamine and norepinephrine activity is proposed to regulate schizophrenic behavior.
• Schizophrenia pathogenesis likely involves a complex interplay of neural developmental disturbances, genetic vulnerability, and environmental influences.